Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors

This comprehensive volume, edited by Hari Shanker Sharma, presents the latest advancements in nanowired delivery of drugs and antibodies for neuroprotection in brain diseases with co-morbidity factors. As part of the esteemed International Review of Neurobiology series (Volume 172), this book features contributions from a distinguished panel of international experts.

Cutting-Edge Research and Breakthroughs

• Spinal Cord Injury and Alzheimer’s Disease: Discover how topical application of nanowired cerebrolysin and antibodies to tumor necrosis factor alpha can reduce spinal cord injury-induced exacerbation of Alzheimer’s disease pathophysiology.
• Nanodelivery of Histamine H3 Receptor Inverse Agonist: Learn about the potentiation of neuroprotection in spinal cord injury using nanodelivery of histamine H3 receptor inverse agonist BF-2549 with clobenpropit, a H3 receptor antagonist and H4 receptor agonist, and antioxidant compound H-290/51.
• Neuromodulation and Quality of Life: Explore the latest findings on neuromodulation and quality of life for patients with spasticity after spinal cord injury.

Treatment of Parkinson’s Disease and Beyond

This volume also delves into the efficacy of invasive and non-invasive methods for the treatment of Parkinson’s disease, including nanodelivery and enriched environment. Additionally, it covers the co-administration of DL-3-n-butylphthalide and neprilysin for neuroprotection in Alzheimer’s disease associated with brain injury.

Neurotoxicity and Neuroprotection

Understand the exacerbation of nicotine neurotoxicity following engineered Ag and Cu (50-60 nm) nanoparticles intoxication, and the neuroprotection achieved with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron.

With its comprehensive coverage of the latest research and breakthroughs, this book is an indispensable resource for neuroscientists, researchers, and clinicians seeking to advance our understanding of nanowired delivery of drugs and antibodies for neuroprotection in brain diseases with co-morbidity factors.

Publication Details: Publisher: Elsevier Science; Release Date: October 16, 2023; Language: English; ISBN: 9780443294686, 9780443294693